By Business/Source
Currency:EUR
2025/FY
Stock NameRevenueRatio
Biopharmaceutical and Diagnostic Solutions1.04B87.70%
Engineering281.01M23.69%
Adjustments, eliminations and unallocated items-135.06M-11.39%
By Country/Region
Currency:EUR
2025/FY
Stock NameRevenueRatio
EMEA690.34M58.19%
North America362.06M30.52%
APAC101.48M8.55%
South America32.4M2.73%